vs
HomeTrust Bancshares, Inc.（HTB）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
RHYTHM PHARMACEUTICALS, INC.的季度营收约是HomeTrust Bancshares, Inc.的1.1倍（$57.3M vs $53.6M），RHYTHM PHARMACEUTICALS, INC.同比增速更快（36.9% vs 3.7%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（48.5% vs 3.5%）
HomeTrust Bancshares, Inc.是总部位于美国北卡罗来纳州阿什维尔的银行控股公司，总资产达43亿美元，在北卡、南卡、佐治亚和田纳西州共设有33家网点，旗下拥有HomeTrust银行、Tryon联邦银行等七家社区银行。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
HTB vs RYTM — 直观对比
营收规模更大
RYTM
是对方的1.1倍
$53.6M
营收增速更快
RYTM
高出33.2%
3.7%
两年增速更快
RYTM
近两年复合增速
3.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $53.6M | $57.3M |
| 净利润 | — | $-47.5M |
| 毛利率 | — | 91.6% |
| 营业利润率 | 37.0% | -82.2% |
| 净利率 | — | -83.0% |
| 营收同比 | 3.7% | 36.9% |
| 净利润同比 | — | -9.6% |
| 每股收益（稀释后） | $0.93 | $-0.73 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HTBRYTM
| Q4 25 | $53.6M | $57.3M | ||
| Q3 25 | $54.1M | $51.3M | ||
| Q2 25 | $54.4M | $48.5M | ||
| Q1 25 | $50.9M | $32.7M | ||
| Q4 24 | $51.7M | $41.8M | ||
| Q3 24 | $50.6M | $33.3M | ||
| Q2 24 | $50.6M | $29.1M | ||
| Q1 24 | $50.0M | $26.0M |
净利润HTBRYTM
| Q4 25 | — | $-47.5M | ||
| Q3 25 | $16.5M | $-52.9M | ||
| Q2 25 | $17.2M | $-46.6M | ||
| Q1 25 | $14.5M | $-49.5M | ||
| Q4 24 | — | $-43.3M | ||
| Q3 24 | $13.1M | $-43.6M | ||
| Q2 24 | $12.4M | $-32.3M | ||
| Q1 24 | $15.1M | $-141.4M |
毛利率HTBRYTM
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
营业利润率HTBRYTM
| Q4 25 | 37.0% | -82.2% | ||
| Q3 25 | 38.5% | -102.6% | ||
| Q2 25 | 40.1% | -93.4% | ||
| Q1 25 | 36.2% | -143.7% | ||
| Q4 24 | 35.4% | -98.6% | ||
| Q3 24 | 33.2% | -132.0% | ||
| Q2 24 | 31.3% | -139.2% | ||
| Q1 24 | 38.0% | -538.7% |
净利率HTBRYTM
| Q4 25 | — | -83.0% | ||
| Q3 25 | 30.5% | -103.1% | ||
| Q2 25 | 31.6% | -96.1% | ||
| Q1 25 | 28.5% | -151.4% | ||
| Q4 24 | — | -103.6% | ||
| Q3 24 | 25.9% | -131.2% | ||
| Q2 24 | 24.6% | -110.9% | ||
| Q1 24 | 30.1% | -544.4% |
每股收益（稀释后）HTBRYTM
| Q4 25 | $0.93 | $-0.73 | ||
| Q3 25 | $0.95 | $-0.82 | ||
| Q2 25 | $1.00 | $-0.75 | ||
| Q1 25 | $0.84 | $-0.81 | ||
| Q4 24 | $0.83 | $-0.71 | ||
| Q3 24 | $0.76 | $-0.73 | ||
| Q2 24 | $0.73 | $-0.55 | ||
| Q1 24 | $0.88 | $-2.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $324.7M | $388.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $600.7M | $139.1M |
| 总资产 | $4.5B | $480.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资HTBRYTM
| Q4 25 | $324.7M | $388.9M | ||
| Q3 25 | $315.8M | $416.1M | ||
| Q2 25 | $297.2M | $291.0M | ||
| Q1 25 | $299.8M | $314.5M | ||
| Q4 24 | $279.2M | $320.6M | ||
| Q3 24 | $293.5M | $298.4M | ||
| Q2 24 | $294.2M | $319.1M | ||
| Q1 24 | $380.5M | $201.2M |
股东权益HTBRYTM
| Q4 25 | $600.7M | $139.1M | ||
| Q3 25 | $595.8M | $148.8M | ||
| Q2 25 | $579.3M | $-11.9M | ||
| Q1 25 | $565.4M | $18.9M | ||
| Q4 24 | $551.8M | $21.7M | ||
| Q3 24 | $540.0M | $11.2M | ||
| Q2 24 | $523.6M | $39.3M | ||
| Q1 24 | $513.2M | $61.6M |
总资产HTBRYTM
| Q4 25 | $4.5B | $480.2M | ||
| Q3 25 | $4.6B | $506.9M | ||
| Q2 25 | $4.6B | $372.7M | ||
| Q1 25 | $4.6B | $386.7M | ||
| Q4 24 | $4.6B | $392.3M | ||
| Q3 24 | $4.6B | $363.6M | ||
| Q2 24 | $4.7B | $381.8M | ||
| Q1 24 | $4.7B | $258.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $49.5M | $-25.4M |
| 自由现金流经营现金流 - 资本支出 | $45.3M | — |
| 自由现金流率自由现金流/营收 | 84.5% | — |
| 资本支出强度资本支出/营收 | 7.8% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $93.8M | — |
8季度趋势，按日历期对齐
经营现金流HTBRYTM
| Q4 25 | $49.5M | $-25.4M | ||
| Q3 25 | $-11.3M | $-26.6M | ||
| Q2 25 | $-8.8M | $-23.3M | ||
| Q1 25 | $71.7M | $-40.4M | ||
| Q4 24 | $45.4M | $-18.8M | ||
| Q3 24 | $43.8M | $-25.2M | ||
| Q2 24 | $5.9M | $-29.1M | ||
| Q1 24 | $-9.0M | $-40.7M |
自由现金流HTBRYTM
| Q4 25 | $45.3M | — | ||
| Q3 25 | $-12.0M | — | ||
| Q2 25 | $-10.2M | — | ||
| Q1 25 | $70.7M | — | ||
| Q4 24 | $42.4M | — | ||
| Q3 24 | $43.1M | — | ||
| Q2 24 | $5.7M | — | ||
| Q1 24 | $-9.6M | — |
自由现金流率HTBRYTM
| Q4 25 | 84.5% | — | ||
| Q3 25 | -22.2% | — | ||
| Q2 25 | -18.7% | — | ||
| Q1 25 | 138.7% | — | ||
| Q4 24 | 82.0% | — | ||
| Q3 24 | 85.1% | — | ||
| Q2 24 | 11.2% | — | ||
| Q1 24 | -19.2% | — |
资本支出强度HTBRYTM
| Q4 25 | 7.8% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 5.9% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 1.1% | — |
现金转化率HTBRYTM
| Q4 25 | — | — | ||
| Q3 25 | -0.68× | — | ||
| Q2 25 | -0.51× | — | ||
| Q1 25 | 4.93× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.34× | — | ||
| Q2 24 | 0.48× | — | ||
| Q1 24 | -0.60× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
